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Abstract 
Ischemia is often implicated as a cause of acute renal failure. We have investigated the effect of various concentrations of extracellular 
Mg2+ on the post-ischemic recovery of ATP and low intracellular Na+ in the isolated perfused rat kidney using 3’P and triple-quantum 
filtered (TQ) 23Na-NMR spectroscopy. Following a 1 h period of stopped flow ischemia, the kidneys exposed to 0.3 mM Mg2+ 
throughout the experiment exhibited a significantly ( p < 0.05) decreased post-ischemic fractional recovery of ATP (56 f 7%) as well as a 
significantly ( p < 0.05) increased accumulation of Pi (250 + 30%) as compared to kidneys exposed to 1.2 mM Mg*’ throughout 
(88 + 5% recovery of [ATP] and 158 & 8% accumulation of [Pi]). Kidneys exposed fo 0.3 mM Mg2+ during the pre-ischemic and 
ischemic periods but to 1.2 mM Mg2+ during reperfusion also showed better recovery of ATP (83 f 6%) and lower accumulation of Pi 
(143 k 8%) compared to kidneys exposed to low Mg 2+ (0.3 mM) throughout the experiment. Measurements of the 23Na TQ signal 
following ischemia-reperfusion revealed that kidneys exposed to 1.2 mM Mg2+ exhibited significantly improved maintenance of low 
intracellular Na+ as compared to those exposed to 0.3 mM Mg2+ ([Na+Ji = 107 + 7% in 1.2 mM Mg2+ vs. 152 ). 3% in 0.3 mM 
Mg*‘). No significant difference was found in the pre-ischemic basal intracellular free Ca*+ level (as measured by 19F-NMR in 
combination with 5 FBAPTA) between kidneys perfused with 1.2 mM and 0.3 mM Mg2+, and comparable depletion of ATP occurred 
during ischemia under both experimental conditions. These data indicate that increased extracellular Mg 2c has a protective effect against 
post-ischemic damage, probably related to its role in resynthesis of ATP during post-ischemic reperfusion. Our results would imply a 
greater vulnerability of the kidney to ischemic damage in hypomagnesemic clinical conditions such as alcoholism and diabetes. 
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1. Introduction 
There is a large amount of evidence implicating is- 
chemia as a cause of acute renal failure [l]. Post-ischemic 
acute renal failure includes such pathophysiologic states as 
trauma, sepsis and postoperative hemorrhage which result 
in renal hypoperfusion and subsequent renal failure [2]. 
Several reports of acute renal failure associated with renal 
transplantation have indicated a correlation between warm 
ischemia time and the incidence of acute tubular necrosis 
[31. 
It has been previously shown that renal ATP levels are 
severely decreased during ischemia [4,5] and that recovery 
of ATP during reperfusion is incomplete[6,7]. In vivo 
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31P-NMR studies have shown that the percent recovery of 
ATP decreased with the duration of the ischemic insult [7]. 
Previous studies have shown that elevated extracellular 
Mg*+ has a beneficial effect [8], while decreased extracel- 
lular Mg *+ has a detrimental effect [9] on the perfused 
working heart. Extracellular Mg*’ has been found to have 
a beneficial effect on the post-ischemic myocardium [lo- 
121. An elevated extracellular Mg*+ was found to enhance 
the rate of post-ischemic recovery of high energy phos- 
phates in the perfused heart [lo] while an acute reduction 
in extracellular Mg*+ was found to impair post-ischemic 
recovery of cardiac function and metabolism [12]. 
Several 3’P-NMR studies in vivo [13-151 as well as in 
the perfused kidney[l6] have examined the effect of post- 
ischemic addition of ATP-MgCl, on intracellular ATP 
recovery. An enhanced recovery of ATP was found in the 
majority of studies [ 13,14,16] although one study found no 
effect of post-ischemic ATP-MgCl, addition on the kidney 
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ATP recovery [15]. Direct effects of extracellular Mg*+ 
addition on the recovery of intracellular Na’ and ATP 
have not heretofore been investigated. 
Hypomagnesemia is a serious clinical problem associ- 
ated with many clinical conditions such as diabetes [17], 
alcoholism [18] as well as several cardiac diseases [19,20]. 
A lower plasma Mg2+ concentration, in time, may impair 
post-ischemic renal function and may render the kidney 
more sensitive to acute renal failure. The effects of re- 
duced extracellular Mg*+ on the post-ischemic recovery of 
ATP and intracellular cations in the kidney have not been 
investigated. In this study we examined the effects of 
elevated (1.2 mM) as well as reduced (0.3 mM) extracellu- 
lar Mg*+ on the recovery of ATP and maintenance of low 
intracellular Na+ upon reperfusion following a 1 hour 
period of ischemic insult on the perfused rat kidney using 
3’P- and triple-quantum filtered (TQ) 23Na NMR spec- 
troscopy. 
2. Experimental 
2.1. Kidney per-j&on 
All experiments were performed on perfused kidneys 
from Sprague-Dawley rats (220-350 g>. Pentobarbital 
anesthesia (65 mg/kg i.v.> was administered; laparotomy 
was performed, and the right kidney was cannulated and 
perfused at a flow rate of 30 ml/(min gm wet wt> through 
the mesenteric and renal artery (without intervening peri- 
ods of ischemia). The opposite non-perfused kidney was 
removed, trimmed of fat and used to determine kidney 
weight. The perfusate consisted of bicarbonate-buffered 
Krebs-Henseleit solution enriched with dialyzed bovine 
serum albumin (6.7% w/v), 5 mM glucose, 5 mM lactate, 
10 mM glutamine, 1 mM glycine and 1 mM adenosine, 
gassed with 95%0,/5%CO, and maintained at 37°C. All 
measurements were performed in phosphate containing 
medium (1 mM, pH 7.4). The perfusion pressure was 
monitored on a Micro Med Blood Pressure Analyzer with 
a transducer connected to the cannula and was corrected 
for the resistance of the cannula. 
2.2. NMR measurements 
31 P and 23Na TQ spectra were collected on the same 
kidney. A series of 3’ P-NMR spectra were collected ini- 
tially at extracellular Mg*+ concentration of 1.2 or 0.3 
mM for 1 hour and 15 minutes. The probe was then tuned 
to 23Na and severa123Na TQ spectra were acquired to 
ensure a stable value was obtained. The perfusate flow was 
then stopped and an ischemic period of 1 hour followed. 
At the end of the hour a 31 P-NMR spectrum was collected 
to examine depletion of intracellular ATP. A 23Na TQ 
spectrum was also collected after 1 hour of ischemia. The 
flow was then restarted and, after 10 minutes of reperfu- 
sion, collection of a second series of 3’ P spectra was 
started to monitor ATP recovery. After 1.5 hours of reper- 
fusion several 23Na TQ spectra were acquired. Three sets 
of experiments were conducted in this manner with the 
extracellular Mg*+ concentration at 1.2 mM throughout, 
0.3 mM throughout, and 0.3 mM through the control and 
ischemic periods but changed to 1.2 mM during reperfu- 
sion. 
2.3. j’P-NMR Measurements 
31 P-NMR spectra were acquired on a Bruker/GE 
Omega 400WB spectrometer operating at 162 MHz using 
60” pulses, a 1.8 second recycle time, and a spectral width 
of 20000 Hz; 500 transients were collected at 37°C. Intra- 
cellular free Mg*+ was calculated using the chemical shift 
difference between the (Y- and Pphosphotyl resonances 
of ATP (asp, in Hz) by the equations [21]: 
[Mg2+li, = KpgATp( c#-’ - 1) 
and 
where a,$ is the value of aas for the kidney, au”p” and 
aMgATP are the values of Sap in noncellular ATP and 
$ATP solutions under simulated intracellular ionic con- 
ditions and pH. A KpATP of 50 PM, a$sATP of 1340 
Hz, and <SJlp - aa$sATP) of 412 Hz, measured on stan- 
dard solutions, at pH 7.3 and 37°C were used in the 
calculation of free Mg*+. 
2.4. 23Na-NMR measurements 
The 23Na-NMR measurements were conducted at 106 
MHz, 37°C using a 0.21 second acquisition time and a 
5000 Hz spectral width. 23Na-TQ NMR spectra were 
collected using the following pulse sequence [22]: 
90,” - r/2 - 180Yo - r/2 - 90; - A - 90; 
- t( acquisition) 
where T is the triple quantum preparation time and A, the 
triple quantum evolution time. The basic six step phase 
cycling of the preparation sequence given by Braun- 
schweiler [23] and the 180” pulse and receiver phases of 
the exorcycle scheme [24] were used to eliminate other 
coherences and artifacts. An evolution time of 15 ~LS was 
used. A T value of 4 ms was used in these experiments 
since this value had been shown to give nearly maximum 
TQ signal intensity. The 23Na TQ spectra were quantitated 
measuring the resonance area above the baseline at the r 
value corresponding to maximum signal and were normal- 
ized by dividing this area by the kidney weight. 
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2.5. Measurement of Intracellular Free Ca’ ’ 
Free Ca’+ concentrations were measured in 
SFBAPTA-loaded kidneys using lYF-NMR at 376 MHz, a 
spectral width of 20000 Hz and 2000 scans were collected. 
For acquisition of “F spectra a recycle time of 0.4 set was 
found to be adequate since the ratio of the areas of the 
CaSFBAPTA and the SFBAPTA resonances was un- 
changed upon increasing the recycle time to 1.6 sec. The 
intracellular indicator SFBAPTA was loaded into the cells 
using its membrane-permeant acetoxymethylester deriva- 
tive. as previously described [25]. The intracellular free 
Ca’+ concentration was determined from the areas under 
the Ca’+-bound SFBAPTA (Abound) and the free SFBAPTA 
( A,.,,,) resonances using the following equation: 
w + 1 = Kd( Abound/A free> 
The K, at 37°C for CaSFBAPTA was previously deter- 
mined in our laboratory to be 492 + 33 nM [26]. 3’ P-NMR 
and 0, consumption measurements were made on the 
SFBAPTA loaded kidneys to determine tissue viability. 
The SFBAPTA-loaded kidneys maintained ATP and con- 
tinued to consume 0, at a rate comparable to the unloaded 
kidneys. The free Ca’+ value for each kidney was deter- 
mined from the average of three stable 13 min. 19F spectra. 
3. Results 
Fig. 1, Fig. 2, and Fig. 3 show sample 3’ P-NMR spectra 
of perfused kidneys at the end of a 1 hour control perfu- 
sion period, after a 1 hour period of ischemia and after a 1 
hour period of reperfusion with various extracellular Mg*+ 
concentrations. The medium in Fig. 1 contained 1.2 mM 
Mg*+ throughout the pre-ischemic, ischemic and post- 
ischemic periods (group 1). Similar 3’ P spectra during 
ischemia and recovery were obtained with 4.8 mM extra- 
cellular Mg*‘. The medium in Fig. 2 contained 0.3 mM 
Mg’+ through the pre-ischemic and ischemic periods but 
was switched to 1.2 mM Mg*+ during recovery (group 2). 
The medium in Fig. 3 contained 0.3 mM Mg2+ throughout 
the experiment (group 3). The similarity of spectra in Fig. 
la, Fig. 2a, and Fig. 3a attest to the maintenance of ATP 
and adequacy of perfusion during the control periods at 
various Mg” levels. The resonances of the CY-, p- and 
y-phosphoryl groups of ATP as well as the sugar phos- 
phate, the intracellular P, and glycerol-3-phosphoryl choline 
are readily identifiable. The viability of the preparation is 
indicated by the similarity of the intensities (areas) of the 
y- and P-phosphoryl group resonances of ATP and the 
low P,/ATP intensity ratio in the control spectra. The ATP 
levels were compared after dividing the integral of the /3 
resonance of ATP by the weight of the opposite nonper- 
fused kidney. The control levels of ATP were not signifi- 
cantly different in all 3 groups (Table 1) indicating that 
external Mg ‘+ concentration does not affect kidney basal 
Fig. 1. Representative ” P-NMR spectra of a kidney after: (a) a control 
perfusion period, (b) a 1 h ischemic period, and (c) a I h reperfusion 
period with I .2 mM Mg’+ in the medium throughout the experiment. 
ATP levels. The spectra in Fig. lb, Fig. 2b, and Fig. 3b are 
the 3’ P spectra of the kidney after 1 hour of ischemia. At 
the end of the ischemic period, ATP is depleted to levels 
less than 10% of the control under all 3 medium condi- 
tions. The Fig. lc, Fig. 2c, and Fig. 3c indicate the 3’P 
spectra after an hour of reperfusion with various extracel- 
lular Mg*+ concentrations. Table 1 gives the average 
pATP and Pi recovery ratios for the 3 groups normalized 
to their respective controls. It is clear from the experimen- 
tal data (Figs. l-3 and Table 1) that an elevated extracellu- 
lar Mg*+ concentration during ischemic and reperfusion 
periods or during the reperfusion period alone elicits sig- 
nificantly better recovery of pATP and return of low Pi as 
compared to reperfusion with reduced (0.3 mMI Mg*+. 
The data further indicate that there is no significant differ- 
ence in the phosphometabolite recovery when elevated 
Mg*+ is present throughout the experiment or only during 
reperfusion. Intracellular free Mg’+ concentrations were 
also measured during the control period and after 1 hour of 
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Fig. 2. Representative 3’P-NMR spectra of a kidney after: (a) a control 
perfusion period with 0.3 mM Mg ‘+, (b) a 1 h ischemic period with 0.3 
mM Mg*+, and (c) a 1 h reperfusion period with 1.2 r&I Mg*+. 
reperfusion for the two extracellular Mg” concentrations. 
There was no significant difference in control intracellular 
free Mg*+ concentration between kidneys perfused with 
1.2 mM Mg*+ (n = 4, 0.53 f 0.04 mM) and 0.3 mM 
Mg*+ (n = 12, 0.68 f 0.05 rnM). There was also no 
significant difference in intracellular free Mg2+ at the end 
of 1 hour reperfusion between kidneys perfused with 1.2 
mM Mg*+ (n = 8, 0.62 + 0.07 mM) and 0.3 mM Mg*+ 
(n = 7, 1.01 f 0.20 mM). 
Figs. 4 and 5 show representative 23Na TQ spectra 
recorded prior to ischemia and after 1 hour of post-ischemic 
reperfusion in kidneys perfused with 1.2 mM Mg*’ and 
with 0.3 mM Mg*+, respectively. 23Na TQ spectra at 4.8 
mM extracellular Mg*+ were similar to those obtained at 
1.2 mM extracellular Mg*+. The 23Na TQ difference 
spectra between the post-recovery TQ signal and the con- 
trol TQ signal are shown in Fig. 4c and Fig. 5c. Table 2 
gives the 23Na TQ signal intensities (normalized to the 
respective pre-ischemic control) following an ischemic 
interval of 1 hour and after 1 hour of post-ischemic 
JL 
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Fig. 3. Representative “P-NMR spectra of a kidney after: (a) a control 
perfusion period, (b) a 1 h ischemic period, and (c) a 1 h reperfusion 
period with 0.3 mM Mg *+ in the medium throughout the experiment. 
reperfusion at the different extracellular Mg*+ concentra- 
tions. Extracellular Mg2+ of 4.8 mM yielded results indis- 
tinguishable from those obtained at 1.2 mM Mg*+. There 
was no significant difference in the basal 23Na TQ signal 
per unit kidney weight at 0.3 mM and 1.2 mM extracellu- 
1arMg , *+ the measured intensities being 1.60 + 0.18 and 
1.43 k 0.25, respectively, in arbitrary units. The data in 
Table 2 indicate that the intracellular Na+ is increased to 
the same extent at the end of a 1 hour ischemic insult in 
the kidney regardless of the extracellular Mg*+ concentra- 
Table 1 
Fractional recoveries of [ATP] and [Pi] with extracellular Mg*+ 
Group ]ATP]/]ATP], rpi l/Lpi 1, 
1 (n=4) 0.88*.05 * 1.58f.08 * 
2(n=4) 0.83f.06 * 1.43f.08 ’ 
3(n=7) 0.56 f .07 2.50* .30 
* Significantly different from group 3 (P < 0.05). 
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Fig. 4. Representative “Na TQ spectra from a kidney perfused with 1.2 
mM Mg’+ after: (a) a post-ischemic 1 h period of reperfusion, (b) a 
pre-ischemic control period, and (c) the difference. spectrum a-b (the 
gain in spectrum c is increased by a factor of 2). 
tion. However, after a 1.5 hour period of post-ischemic 
reperfusion, the intracellular Naf recovered to low values 
closer to those of the control when the kidney was per- 
fused with elevated Mg*+ (1.2 or 4.8 mM) than when it 
was perfused at low Mg2+ (0.3 mM). There was also 
significantly better recovery of ATP and return of low Pi 
in kidneys perfused with 1.2 mM Mg2+ than in kidneys 
perfused with 0.3 mM Mg2+. The value of the fractional 
recovery of the 23Na TQ signal of kidneys in group 2 (0.3 
mM Mg *+ during pre-’ tschemic and ischemic periods 
switched to 1.2 mM Mg*+ during the reperfusion period) 
was 1.33 It: 0.12. This indicates an incomplete removal of 
intracellular Naf when external Mg2+ is elevated during 
reperfusion only. An elevated extracellular Mg*+ during 
both ischemia as well as reperfusion clearly leads to better 
maintenance of low intracellular Na+ upon reperfusion. 
To determine whether the effect of extracellular Mg2+ 
on recovery of the kidney from ischemia arose from the 
maintenance of a different level of basal [Ca2’li, intra- 
cellular free Ca2+ was measured in kidneys perfused with 
A a 
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Fig. 5. Representative “Na TQ spectra from a kidney perfused with 0.3 
mM Mg’+ after: (a) a post-ischemic 1 h reperfusion period, (b) a 
pre-ischemic control perfusion period, and (c) the difference spectrum 
a-b (gain in spectrum c is increased by a factor of 2). 
different extracellular Mg*+ concentrations (1.2 and 0.3 
mM). We found no significant difference in basal intra- 
cellular free Ca2+ levels between kidneys perfused with 
2+ 1.2mMMg ( _ 467 + 34 nM) and kidneys perfused with 
0.3 mM Mg2+ (541 + 14 nM). The measured values of 
[Ca2+li in the intact perfused kidney are somewhat higher 
than those measured in isolated kidney cells [27,28]. The 
higher values are reproducible and must reflect the altered 
calcium homeostasis of the intact organ. It is unlikely that 
higher values are due to the presence of basal &hernia. 
Table 2 
Normalized *‘Na TQ signals during ischemia and recovery 
[Mg*+ I, [Nat l/lNa+ I, lNa+ l/lNa+ I, 
Ischemia ( 1 h) Recovery ( 1 h) 
0.3mM (n = 6) 1.70+.17 1.52k.03 * 
1.2mM(n=4) 1.78k.17 1.07+.07 
* Significantly different from value at 1.2 mM (P < 0.001) 
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The 3’ P spectra of our perfused kidneys are similar to 
those observed in-vivo [29]. 
Perfusion pressure was measured at the beginning prior 
to the onset of &hernia and at the end of the post-ischemic 
reperfusion period. No significant difference in perfusion 
pressure was found in the pre-ischemic period for the 
kidneys exposed to the 2 different Mg2+ concentrations 
(117 + 6 mmHg at 1.2 mM Mg*+ vs. 115 + 7 mmHg at 
0.3 mM Mg2+ I. Perfusion pressures found at the end of 
the recovery period in kidneys perfused with 1.2 mM 
Mg*+ (128 + 14 mm Hg, iz = 5) and with 0.3 mM Mg’+ 
(158 k 11 mm Hg, y1= 4) were also not found to be 
significantly different. 
4. Discussion 
We have shown in this study that an increased extracel- 
lular Mg2+ concentration (1.2 mM or 4.8 mM) during the 
entire ischemia-recovery period, or only during reperfu- 
sion, significantly enhances the recovery of ATP and 
return of low intracellular Pi in the kidney. We have also 
shown that perfusion with increased extracellular Mg*+ 
(1.2 mM or 4.8 mM) also significantly improves the 
post-ischemic maintenance of low intracellular Na+ as 
compared to perfusion with lowered extracellular Mg*+ 
(0.3 mM). These results were not due to a difference in 
basal ATP, intracellular [Na+], or intracellular free [Ca2+], 
since there were no significant differences found in basal 
ATP, free [Ca2+li or in the 23Na TQ signal at 1.2 mM and 
0.3 mM extracellular Mg*+ concentrations before the on- 
set of the ischemic insult. 
A similar effect of Mg*+ on the recovery of ATP after 
ischemic insult has previously been reported in other or- 
gans. In the isolated perfused heart, elevated extracellular 
Mg2+ (I 5 mM) during reperfusion has been reported to 
give significantly enhanced recovery of ATP following an 
ischemic insult [lo]. Lower extracellular Mg’ + has been 
found to result in reduced ATP in hearts following an 
ischemic insult [ 121. 
Previous 3’P-NMR studies have shown that post- 
ischemic ATP-MgCl, addition enhances ATP recovery in 
vivo [ 13,141 and in the isolated perfused kidney [ 141. It has 
also been reported that post-ischemic infusion of ATP- 
MgCl, or AMP-MgCl, produced similarly enhanced ATP 
levels in vivo [14]. One study, however, reported no 
improvement in ATP levels with ATP-MgCl, addition in 
the kidney in vivo[ 151. The effect of post-ischemic infu- 
sion of ATP-MgCl, enhancing the ATP levels has been 
thought to be due to extracellular catabolism of ATP to 
AMP which is further degraded to adenosine, which is 
then taken up into the cell by adenosine transport systems 
providing precursors for ATP synthesis [30,3 11. It has been 
found, however, that enhanced functional recovery from 
renal ischemia requires the infusion of both the adenine 
nucleotides and MgCl, [32]. Based on our studies, we 
suggest that part of the improvement in recovery observed 
in these studies may be due to the increase in [Mg”] 
which will be released from MgATP or MgADP upon 
hydrolysis by extracellular enzymes. The reported lack of 
an effect of ATP-MgCl, in one study may be related to 
lack of sufficient ATP hydrolysis to appreciably change 
free Mg*+ under the conditions used in that study. 
Whether the effect of Mg*+ on ischemia/recovery 
requires the presence of adenosine remains unknown since 
in our study we had a constant concentration of adenosine 
in the perfusion medium along with increased (4.8 mM or 
1.2 mM) or decreased (0.3 mM) extracellular Mgzf. How- 
ever, even in the presence of this precursor for ATP 
synthesis, a reduced extracellular concentration of Mg2+ 
led to reduced recovery of post-ischemic ATP levels. Thus 
our study reveals the importance of Mg’+ in enhancing 
post-ischemic recovery of ATP levels. 
In this study we also found better recovery of intra- 
cellular Naf with increased extracellular Mg*‘. The entry 
of Na+ is through the Na’/H+ exchanger on the brush 
border membrane and the extrusion of Na+ from the cell is 
via the Na+/K+-ATPase on the basolateral membrane of 
the proximal tubule. The enhanced recovery of ATP at 
higher Mg 2 + concentrations providing more ATP for the 
Na+/K+-ATPase could result in a lower post-ischemic 
level of intracellular Na+ at 4.8 mM or 1.2 mM Mg’+ 
versus 0.3 mM Mg . *+ However, there is also evidence for 
a direct effect of extracellular Mg*+ on the Na+-Kf- 
ATPase. In the perfused heart, higher extracellular Mg’+ 
concentrations were found to conserve myocardial Kf 
[lo]. A study measuring the effect of extracellular Mg’+ 
on 86Rb uptake in an atria1 cell line showed that increasing 
extracellular Mg2+ from 0 or 0.6 mM to 1.2 mM resulted 
in significantly higher 86Rb uptake [33]. The ouabain 
sensitive component (a measure of the Na+/K+-ATPase 
activity) was found to represent the majority of the s6Rb 
uptake and to be inhibited significantly at reduced extracel- 
lular Mg*+ concentration [33]. It was concluded that extra- 
cellular Mg*+ is important for shRb transport in cardiac 
cells and suggested that the main effect is on the 
Na+/K’-ATPase component of transport [33]. A direct 
effect of extracellular Mg*+ in enhancing the Na+/K+- 
ATPase activity, however, does not seem to be responsible 
for our observations of a lower intracellular Na+ in high 
extracellular Mg*’ following ischemia-reperfusion since 
altering extracellular Mg’+ prior to ischemia did not affect 
intracellular Na+. The somewhat higher level of Na+ 
when elevated Mgzi was present during the reperfusion 
period alone may be due to the fact that higher Mg*+ 
during ischemia may protect slightly against ATP deple- 
tion. The ATP levels at the end of the ischemic period 
were too low to be measured by 31 P-NMR and thus we 
could not obtain direct evidence for supporting this hy- 
pothesis. 
A possible mechanism for the improvement of 
postreperfusion ATP levels with elevated Mg2’ may be 
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through extracellular Ca2+ antagonism and an inhibition of 
an initial Ca*+ influx during ischemia. However, no effect 
of extracellular Mg2+ on intracellular free Ca2+ was 
observed during the pre-ischemic period arguing against 
this possibility. A similar conclusion was obtained in a 
ischemia-recovery study of isolated perfused hearts [IO]. 
Thus a reduced Ca*’ influx via Ca*+-Mg*+ antagonism 
does not appear to be the primary mechanism for the 
improvement in renal metabolism with elevated Mg*+. 
Another mechanism for the protective role of extracellu- 
lar Mg2+ on the kidney may be due to its effect on renal 
perfusate flow since Mg2+ may affect reactivity of small 
renal vessels [34] and a decreased concentration of Mg*+ 
might be expected to promote some intra-renal vasculature 
constriction. However, this appears unlikely, since no sig- 
nificant difference in perfusion pressure between kidneys 
exposed to 1.2 mM (or 4.8 mM) Mg*+ and 0.3 mM Mg*+ 
was noticed. It should be noted that the kidney has two 
major arterioles and therefore the absence of a change in 
renal arterial perfusate pressure does not necessarily imply 
no change in vascular resistance or tubular blood flow. 
The possibility also exists that improved post-ischemic 
recovery with elevated Mg’+ may be through improved 
mitochondrial function. It has been shown that increased 
Mg *+ improves mitochondrial respiration in perfused rat 
hearts [35]. A study in the rabbit heart also showed that 
elevated Mg*’ (15 mM) when combined with low Ca*+ 
(0.75 mM) prevented mitochondrial Ca” overload and 
enhanced oxidative phosphorylation [I I]. This effect was 
not reflected in a reduced tissue calcium content [ 1 I]. A 
similar mechanism may be operative with the kidney as 
well. 
Hypomagnesemia is a prevalent clinical condition asso- 
ciated with diabetes[ 171, alcoholism 1181 and several car- 
diac diseases [I 9,201. Markell et al. demonstrated a correla- 
tion between low serum Mg *+ levels and renal failure in 
patients with renal disease [36]. Our findings suggest that 
there may be an enhanced sensitivity of the kidney to 
post-ischemic damage in hypomagnesemic patients. 
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